Xoma | XOMA - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.22B 329M 2026-03
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Ardelyx USD 10.85M 6.87M 2025-12
aTyr Pharma USD 3.34M 18.79M 2025-12
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Curis USD 314K 9.96M 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Incyte USD 104.5M 16.68M 2026-03
MacroGenics USD 10.12M 34.18M 2025-12
Novartis USD 3.46B 83M 2026-03
Novartis USD 3.54B 7M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
Prothena USD 28.94M 11.58M 2025-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Xoma 116K 112.7K 2024-06